1,1-Dihalo-1-(methylsulfonyl)methanesulfonamides
    1.
    发明授权
    1,1-Dihalo-1-(methylsulfonyl)methanesulfonamides 失效
    1,1-二卤代-1-(甲基磺酰基)甲磺酰胺

    公开(公告)号:US3865822A

    公开(公告)日:1975-02-11

    申请号:US32243473

    申请日:1973-01-10

    申请人: DOW CHEMICAL CO

    CPC分类号: C07D295/26

    摘要: The compounds of the formula

    摘要翻译: 式为CH3SO2CX2SO2NR1R2的化合物,其中X为氯或溴,R1和R2独立地为氢,1至16个碳原子的烷基,苯基或取代的苯基,并与氮原子一起表示可含有氧原子或其他氮的杂环 杂环中的原子。 通过在有机溶剂存在下使相应的1-(甲基磺酰基)甲磺酰胺与碱金属次卤酸盐反应制备化合物。 该化合物具有抗菌活性。

    2-phenyl-4-tertiary aminoloweralkyl-2h-1,4-benzoxazin-3(4h)-ones
    2.
    发明授权
    2-phenyl-4-tertiary aminoloweralkyl-2h-1,4-benzoxazin-3(4h)-ones 失效
    2-苯基-4-叔丁基氨基甲基-3H-1,4-苯并恶嗪-3(4H) - 酮

    公开(公告)号:US3557103A

    公开(公告)日:1971-01-19

    申请号:US3557103D

    申请日:1968-07-18

    申请人: PARKE DAVIS & CO

    发明人: NORDIN IVAN C

    IPC分类号: C07D265/36 C07D87/48

    CPC分类号: C07D265/36

    摘要: NOVEL BENZOXAZINONE FREE BASE (I) AND ACID ADDITION SALT COMPOUNDS

    2-PHENYL,4-(A=N-(CH2)N-)-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-3-

    ONE

    ARE PROVIDED BY CONDENSING 2-PHENYL-2H-1,4-BENZOXAZIN3(4H)-ONE WITH THE APPROPRIATE AMINOALKYL SIDE CHAIN IN EITHER ONE OR TWO STEPS WHERE B IS 3, 4 OR 5 AND -N=A IS A DIISOPROPYLAMINO, 2,5-DIMETHYL-1-PYRROLIDINYL OR 2,6DIMETHYLPIPERIDINO GROUP. THE PRODUCTS HAVE PHARMACOLOGICAL PROPERTIES AND ARE USEFUL ANTI-ARRHYTHMIC AGENTS.

    3-amino-2h,5,6-dihydro-1,4-oxazines and salts thereof
    4.
    发明授权
    3-amino-2h,5,6-dihydro-1,4-oxazines and salts thereof 失效
    3-氨基-2H,5,6-二氢-1,4-氧化物及其盐

    公开(公告)号:US3803142A

    公开(公告)日:1974-04-09

    申请号:US27639972

    申请日:1972-07-31

    IPC分类号: C07D265/30 C07D87/48

    CPC分类号: C07D265/30

    摘要: COMPOUNDS OF THE FORMULA

    (R1,R2,R3-PHENYL)-(NH)N-C
    WHEREIN R1, R2 AND R3, WHICH MAY BE INDENTICAL TO OR DIFFERENT FROM EACH OTHER, ARE EACH HYDROGEN, FLUORINE, CHLORINE, BROMINE, ALKYL OF 1 TO 3 CARBON ATOMS, METHOXY, ETHOXY, CYANO OR TRIFLUOROMETHYL, Y IS OXYGEN OR SULFUR, AND N IS 1 OR 2, AND THEIR NON-TOXIC, PHARMACOLOGICALLY ACCEPTABLE ACID ADDITION SALTS; THE COMPOUNDS AS WELL AS THE SALTS ARE USEFUL AS ANALGESICS.

    2,3-dihydro-1,4-benzoxazines
    5.
    发明授权
    2,3-dihydro-1,4-benzoxazines 失效
    2,3-二氢-1,4-苯并恶唑

    公开(公告)号:US3681330A

    公开(公告)日:1972-08-01

    申请号:US3681330D

    申请日:1968-06-04

    发明人: PESSON MARCEL

    摘要: The invention provides 3-oxo-2,3-dihydro-1,4-benzoxanines carrying a carbamoylakyl radical in the 4-position which have useful therapeutic properties as muscle relaxing agents, analgesics, anti-convulsion agents, anti-inflammatories, and anti-pyretics.

    摘要翻译: 本发明提供了在4-位上携带有氨基甲酰基的3-氧代-2,3-二氢-1,4-苯并氧苯胺,其作为肌肉松弛剂,止痛剂,抗惊厥剂,抗炎剂和抗 讽刺。

    3-oxo-2,3-dihydro-1,4-benzoxazine derivatives
    7.
    发明授权
    3-oxo-2,3-dihydro-1,4-benzoxazine derivatives 失效
    3-氧代-2,3-二氢-1,4-苯并恶唑衍生物

    公开(公告)号:US3770734A

    公开(公告)日:1973-11-06

    申请号:US875370

    申请日:1970-02-04

    申请人: BELLON R LAB

    发明人: PESSON M TECHER H

    IPC分类号: C07D265/36 C07D87/48

    CPC分类号: C07D265/36

    摘要: 6 - AMINOALKYL - 3 - OXO-2,3-DIHYDRO-1,4-BENZOXAZINES, WHICH MAY BE MADE BY REACTION OF A SECONDARY AMINE WITH A 6 - HALOALKYL - 3 - OXO-2,3-DIHYDRO-1,4-BENZOXAZINE, AND WHICH MAY BE USED AS CENTRAL NERVOUS DEPRESSANTS.

    3-aryl-benzazines
    10.
    发明授权
    3-aryl-benzazines 失效
    3-ARYL-BENZAZINES

    公开(公告)号:US3829421A

    公开(公告)日:1974-08-13

    申请号:US29887572

    申请日:1972-10-19

    申请人: MERCK PATENT GMBH

    摘要: 3-ARYL-BENZAZINES HAVING SERUM CHOLESTEROL LOWERING ACTIVITY OF THE FORMULA

    1,2-(-N(-Y)-C(-Z)(4-R-PHENYL)-CH(-R3)-Z-),R1-BENZENE

    WHEREIN R1 AND R2 ARE H, OH, ESTERFILED OH, ALKYL, ALKOXY OR BENZYLOXY, R3 IS ALKYL, X IS O OR S, Y IS H OR ACYL AND Z IS H OR Y AND Z COLLECTIVELY ARE A C-H BOND ARE PREPARED BY CYCLIZING OF THE FOLLOWING CLASSES OF COMPOUNDS:

    1-A1,2-((4-R2-PHENYL)-C(=A2)-CH(-R3)-X-),R1-BENZENE II

    1-((4-R2-PHENYL)-C(-Z)(-CH(-B2)-R3)-N(-Y)-),2-B1,R1-

    BENZENE

    WHEREIN A1 IS NH3 OR HALOGEN, A2 IS =O, =S, =NH, (H, NH2) OR (H, HALOGEN), AT LEAST ONE BEING A NITROGEN FUNCTION, AND B1 AND B2 ARE OH, SH OR REACTIVE FUNCTIONAL DERIVATIVES THEREOF, OR (ONE OF B1 AND B2 ONLY) H OR HALOGEN; OR BY REDUCING OR DEHYDRATING COMPOUNDS OF FORMULA 1 AND COMPOUNDS OTHERWISE CORREPSONDING TO FORMULA 1 WHEREIN Z IS OH; OR BY HYDROLYZING OR HYDROGENATING COMPOUNDS OTHERWISE CORRESPONDING TO FORMULA 1 WHEREIN R1 AND/OR R2 IS A FUNCTIONALLY MODIFIED OH GROUP CONVERTIBLE TO AN OH GROUP BY HYDROLYSIS OF HYDROGENOLYSIS.